CASE STUDIES
Improving the outcomes that matter most — for your patients and your practice.
Read about the proven safety and efficacy of the CyberKnife® System for the treatment of trigeminal neuralgia.
Read about the safety and efficacy of CyberKnife SBRT for prostate cancer patients.
Read about the superior clinical outcomes when treating head and neck cancer with helical TomoTherapy® over RapidArc.
.
Page 2 of 4
CASE STUDY
Medically Inoperable Primary Liver Carcinoma
After 9 months the tumor continued to be PET-CT negative and there were no noted side effects from the treatment.
CASE STUDY
Low-Risk Organ-Confined Prostate Cancer
CyberKnife monotherapy produced an early and stable reduction in PSA in a patient with low-risk organ-confined prostate cancer with minimal acute urinary toxicities and no noted chronic toxicities.
CASE STUDY
Pancreatic Adenocarcinoma
The CyberKnife is well-poised to improve the local control rates−this is accomplished with high doses per fraction delivered via a highly conformal approach; improvements in systemic therapy are also necessary, which can easily be sequenced into the treatment as the CyberKnife treatment is of short duration.
CASE STUDY
CyberKnife® Monotherapy for Low-Risk Prostate Cancer
The CyberKnife® System successfully reproduced an HDR-like dose distribution, delivering treatment in a minimally invasive fashion.
CASE STUDY
Spinal Arteriovenous Malformation
The patient was considered to be inoperable, and was referred by the neurosurgeon for radiosurgery using the CyberKnife® Robotic Radiosurgery System.
CASE STUDY
Recurrent Multiple Myeloma at Clivius & C1
CyberKnife® treatments, with sub-millimeter accuracy and highly conformal dosimetry, was the only reasonable option to control the patient’s tumor without causing undue radiation-induced toxicity.
CASE STUDY
Treating Squamous Cell Carcinoma
Six months after radiation treatments, the tumor was gone. The patient’s optic nerve and vision were spared, and the eyeball no longer protruded.
CASE STUDY
SBRT for Non-Small Cell Carcinoma
Using the TomoTherapy® Hi·Art® system’s precise dose guidance capabilities, the oncologist delivered intense radiation directly to the tumor during a week and a half of treatment. The patient experienced no side effects during this time and continued to work as a nurse. Three years later, she remains disease free.
CASE STUDY
Treatment Plan for Prostate Cancer
Highly-homogeneous dose. Excellent bladder and rectal sparing. Excellent small bowel sparing.
CASE STUDY
Posterior Fossa Renal Cell Metastasis
Due to the tumor location, stereotactic radiosurgery (SRS) was indicated in favor of surgery. The patient proactively inquired six months prior regarding the possibility of CyberKnife® treatment should she develop recurrent disease in the lung or brain. SRS is a well recognized technique for the treatment of cerebellar renal cell carcinoma metastases.
